These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33276078)

  • 1. Should We Expand Cardiac Response Criteria in Patients with Light Chain Cardiac Amyloidosis?
    López-Ibor JV; Krsnik I; Gómez-Bueno M; Hernández-Pérez FJ; Durante-López A; Mingo Santos S; Moñivas Palomero V; García-Izquierdo E; Sayago I; Royuela A; Segovia-Cubero J
    J Am Soc Echocardiogr; 2021 Mar; 34(3):318-322. PubMed ID: 33276078
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac Care of Patients with Cardiac Amyloidosis.
    Itzhaki Ben Zadok O; Kornowski R
    Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding and recognizing cardiac amyloidosis.
    McVeigh T; Tennyson C
    JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac amyloidosis: where are we today?
    Patel KS; Hawkins PN
    J Intern Med; 2015 Aug; 278(2):126-44. PubMed ID: 26077367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A first step beyond traditional boundaries: destination therapy with the SynCardia total artificial heart.
    Spiliopoulos S; Koerfer R; Tenderich G
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):855-6. PubMed ID: 24632422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
    Zhang KW; Zhang R; Deych E; Stockerl-Goldstein KE; Gorcsan J; Lenihan DJ
    Am Heart J; 2021 Feb; 232():137-145. PubMed ID: 33212046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the diagnosis and management of cardiac amyloidosis.
    Sher T; Gertz MA
    Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of cardiac bio-marker assay for the stratification and monitoring of AL amyloidosis patients -  single center experience].
    Pika T; Lochman P; Vymětal J; Metelka R; Flodr P; Minařík J; Látalová P; Zapletalová J; Bačovský J; Sčudla V
    Vnitr Lek; 2013 Sep; 59(9):776-81. PubMed ID: 24073949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Grogan M; Dispenzieri A; Gertz MA
    Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis.
    Decker I; Goodman SA; Phillips SE; Lenihan DJ; Cornell RF
    Br J Haematol; 2017 May; 177(3):481-483. PubMed ID: 28295184
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac Light Chain Deposition Disease Mimicking Immunoglobulin Light Chain Amyloidosis: Two Branches of the Same Tree.
    Osanami A; Yano T; Takemura G; Ikeda H; Inyaku M; Toda Y; Kamiyama N; Sugawara H; Gocho Y; Fujito T; Nagano N; Takahashi S; Muranaka A; Tanaka M; Moniwa N; Murase K; Takada K; Kuroda H; Ogawa Y; Miura T
    Circ Cardiovasc Imaging; 2020 Sep; 13(9):e010478. PubMed ID: 32873072
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical features and outcomes of immunoglobulin light-chain amyloidosis with heart involvement].
    Meng L; Ding WH; Shi LB; Gong YJ; Liu ZP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):340-3. PubMed ID: 17711661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
    Kristen AV; Rosenberg M; Lindenmaier D; Merkle C; Steen H; Andre F; Schönland SO; Schnabel PA; Schuster T; Röcken C; Giannitsis E; Katus HA; Frey N
    Amyloid; 2014 Sep; 21(3):202-10. PubMed ID: 25007036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cardiac amyloidosis.
    THOMASHOW AI; ANGLE WD; MORRIONE TG
    Am Heart J; 1953 Dec; 46(6):895-905. PubMed ID: 13104331
    [No Abstract]   [Full Text] [Related]  

  • 16. Case report: isolated cardiac amyloidosis: an enigma unravelled.
    Khalid U; Awar O; Verstovsek G; Cheong B; Yellapragada SV; Jneid H; Deswal A; Virani SS
    Methodist Debakey Cardiovasc J; 2015; 11(1):53-8. PubMed ID: 25793032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heavy and light chain (AHL)-type cardiac amyloidosis: first histopathologic-proven case illustrating involvement of the heart.
    Sekulic M; Pichler Sekulic S; Weins A
    Virchows Arch; 2020 Nov; 477(5):733-738. PubMed ID: 32388718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidosis in Heart Failure.
    Ihne S; Morbach C; Obici L; Palladini G; Störk S
    Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.
    Patel KS; Hawkins PN; Whelan CJ; Gillmore JD
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25535224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types.
    Varga C; Dorbala S; Lousada I; Polydefkis MJ; Wechalekar A; Maurer MS; Comenzo RL
    Blood Rev; 2021 Jan; 45():100720. PubMed ID: 32616304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.